Differential Expression of Lonp1 Isoforms in Cancer Cells
Lonp1 is a mitochondrial protease that degrades oxidized and damaged proteins, assists protein folding, and contributes to the maintenance of mitochondrial DNA. A higher expression of LonP1 has been associated with higher tumour aggressiveness. Besides the full-length isoform (ISO1), we identified two other isoforms of Lonp1 in humans, resulting from alternative splicing: Isoform-2 (ISO2) lacking aa 42-105 and isoform-3 (ISO3) lacking aa 1-196. An inspection of the public database TSVdb showed that ISO1 was upregulated in lung, bladder, prostate, and breast cancer, ISO2 in all the cancers analysed (including rectum, colon, cervical, bladder, prostate, breast, head, and neck), ISO3 did not show significant changes between cancer and normal tissue. We overexpressed ISO1, ISO2, and ISO3 in SW620 cells and found that the ISO1 isoform was exclusively mitochondrial, ISO2 was present in the organelle and in the cytoplasm, and ISO3 was exclusively cytoplasmatic. The overexpression of ISO1 and, at a letter extent, of ISO2 enhanced basal, ATP-linked, and maximal respiration without altering the mitochondria number or network, mtDNA amount. or mitochondrial dynamics. A higher extracellular acidification rate was observed in ISO1 and ISO2, overexpressing cells, suggesting an increase in glycolysis. Cells overexpressing the different isoforms did not show a difference in the proliferation rate but showed a great increase in anchorage-independent growth. ISO1 and ISO2, but not ISO3, determined an upregulation of EMT-related proteins, which appeared unrelated to higher mitochondrial ROS production, nor due to the activation of the MEK ERK pathway, but rather to global metabolic reprogramming of cells.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Cells - 11(2022), 23 vom: 06. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zanini, Giada [VerfasserIn] |
---|
Links: |
---|
Themen: |
ATP-Dependent Proteases |
---|
Anmerkungen: |
Date Completed 29.12.2022 Date Revised 29.12.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/cells11233940 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM350094012 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM350094012 | ||
003 | DE-627 | ||
005 | 20231226044157.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/cells11233940 |2 doi | |
028 | 5 | 2 | |a pubmed24n1166.xml |
035 | |a (DE-627)NLM350094012 | ||
035 | |a (NLM)36497197 | ||
035 | |a (PII)3940 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zanini, Giada |e verfasserin |4 aut | |
245 | 1 | 0 | |a Differential Expression of Lonp1 Isoforms in Cancer Cells |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.12.2022 | ||
500 | |a Date Revised 29.12.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Lonp1 is a mitochondrial protease that degrades oxidized and damaged proteins, assists protein folding, and contributes to the maintenance of mitochondrial DNA. A higher expression of LonP1 has been associated with higher tumour aggressiveness. Besides the full-length isoform (ISO1), we identified two other isoforms of Lonp1 in humans, resulting from alternative splicing: Isoform-2 (ISO2) lacking aa 42-105 and isoform-3 (ISO3) lacking aa 1-196. An inspection of the public database TSVdb showed that ISO1 was upregulated in lung, bladder, prostate, and breast cancer, ISO2 in all the cancers analysed (including rectum, colon, cervical, bladder, prostate, breast, head, and neck), ISO3 did not show significant changes between cancer and normal tissue. We overexpressed ISO1, ISO2, and ISO3 in SW620 cells and found that the ISO1 isoform was exclusively mitochondrial, ISO2 was present in the organelle and in the cytoplasm, and ISO3 was exclusively cytoplasmatic. The overexpression of ISO1 and, at a letter extent, of ISO2 enhanced basal, ATP-linked, and maximal respiration without altering the mitochondria number or network, mtDNA amount. or mitochondrial dynamics. A higher extracellular acidification rate was observed in ISO1 and ISO2, overexpressing cells, suggesting an increase in glycolysis. Cells overexpressing the different isoforms did not show a difference in the proliferation rate but showed a great increase in anchorage-independent growth. ISO1 and ISO2, but not ISO3, determined an upregulation of EMT-related proteins, which appeared unrelated to higher mitochondrial ROS production, nor due to the activation of the MEK ERK pathway, but rather to global metabolic reprogramming of cells | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Lon protease | |
650 | 4 | |a SW620 | |
650 | 4 | |a mitochondria | |
650 | 4 | |a mitochondrial DNA | |
650 | 7 | |a ATP-Dependent Proteases |2 NLM | |
650 | 7 | |a EC 3.4.21.- |2 NLM | |
650 | 7 | |a LONP1 protein, human |2 NLM | |
650 | 7 | |a EC 3.4.21.- |2 NLM | |
650 | 7 | |a Mitochondrial Proteins |2 NLM | |
650 | 7 | |a Protein Isoforms |2 NLM | |
700 | 1 | |a Selleri, Valentina |e verfasserin |4 aut | |
700 | 1 | |a De Gaetano, Anna |e verfasserin |4 aut | |
700 | 1 | |a Gibellini, Lara |e verfasserin |4 aut | |
700 | 1 | |a Malerba, Mara |e verfasserin |4 aut | |
700 | 1 | |a Mattioli, Anna Vittoria |e verfasserin |4 aut | |
700 | 1 | |a Nasi, Milena |e verfasserin |4 aut | |
700 | 1 | |a Apostolova, Nadezda |e verfasserin |4 aut | |
700 | 1 | |a Pinti, Marcello |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cells |d 2011 |g 11(2022), 23 vom: 06. Dez. |w (DE-627)NLM227066421 |x 2073-4409 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2022 |g number:23 |g day:06 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/cells11233940 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2022 |e 23 |b 06 |c 12 |